Evaluation of the effect of topical and systemic ozone application in periodontitis: an experimental study in rats* Objective: The goal of the present study was to determine the effect of systemic and topical ozone application on alveolar bone loss (ABL) by evaluating the effect of Hypoxia-inducible factor -1 alpha (HIF-1-α) and receptor activator of NF-kB ligand (RANKL)-positive cells on histopathological and immunohistochemical changes in a rat periodontitis model. Methodology:
Introduction
Chronic periodontitis is an infectious disease of the periodontium and is characterized by the complex destruction between pathogenic microorganisms and the host response. 1 Microorganisms play a role in the etiology and pathogenesis of periodontitis as well as their toxins, enzymes and similar products, by activating natural and acquired host defense through host-based enzymes. The host response protects the periodontium from local microbial attack and prevents the pathogenic microorganisms from spreading in the tissue, but it can damage periodontium cells and connective tissue, causing destruction of periodontal ligament, alveolar bone and cement. 2 Hypoxia, a sign of chronic inflammation, is the insufficient oxygen supply to cells and tissues. 3 The tissue oxygen requirement is increased due to metabolic activation of inflamed tissue and infiltration of the inflammatory cells in chronic inflammation.
Furthermore, vasoconstriction and microthrombosis cause tissue perfusion to weaken it and a decrease in oxygen supplementation. This results in low-oxygen environment and the accumulation of hypoxiainducible factor alpha in the inflamed area. 4 Hypoxiainducible factor -1 alpha (HIF-1-α) is one of the HIFalfa subunits that are the main sensors of hypoxia. 5 HIF-1-α is the main regulatory protein that provides adaptation to hypoxic conditions.6 HIF-1-α has been shown to be activated by proinflammatory signals in periodontal cells. 7, 8 It has been reported that hypoxia may play an important role in the progression of periodontal disease and the destruction of periodontal tissue. 9 Yu, et al. 10 (2012) stated that the lack of oxygen in periodontal tissue may accelerate the development of periodontitis. It is also known that hypoxia increases the release of receptor activator of NF-kB ligand (RANKL). 10 RANKL is a tumor necrosis factor ligand superfamily member. It is responsible for bone resorption by stimulating osteoclastic differentiation. 11 The binding of RANKL to the RANK receptor on the pre-osteoclast surface induces bone resorption by stimulating mature osteoclastic differentiation. 11 Ozone is a naturally occurring compound containing three oxygen atoms. Ozone has various effects, such as antimicrobial, anti-hypoxic, immune-modulator, biosynthetic and analgesic. It has been medically used in both gaseous and aqueous forms and can be dissolved in either water or oil. 12 Ozone allows oxygen to move inside the tissues more easily by increasing the amount of 2,3-diphosphoglycerate in erythrocytes. Ozone increases the release of nitric oxide, leading to vasodilatation and increase blood flow in tissue. An increase in free oxygen radicals leads to a change in antioxidant enzyme levels and immune system activity. It induces the production of interferon, interleukin, tumor necrotising factor and growth factors in leukocyte and endothelial cells. As a result, ozone therapy can be used for treatment in physio-pathological conditions in which the inflammatory process is intense and the immune system is triggered. 13 There are several studies evaluating the application of local ozone in chronic periodontitis and aggressive periodontitis. [14] [15] [16] [17] The sample size was calculated to provide 80% power (1-β) with a 95% confidence interval (α = 0.05); ten animals per group were required. 18
Thirty male Wistar rats (Rattus norvegicus albinus;
initial body weights ranging between 320-350 g) were dived into three groups as follows; 1) Group C (control group, n:10 rats); 2) Group SO (systemic ozone group, n:10 rats) and 3) Group TO (topical ozone group, n: 
The ozone gas was achieved from a Longevity
Ozone Generator EXT50 (Longevity Resources Inc., Sidney, British Columbia, Canada), and was injected 0.7 mg/kg intraperitoneally, according to the previous study. 21 The topical ozone application was performed with an ozone generator (OzoneDTA generator, APOZA, Taiwan) at 80% concentration (4 th grade) 90-degree probe for 30 seconds. 22 Both systemic and topical ozone applications were carried out for two weeks at two days intervals (on days 0, 2, 4, 6, 8, 10, 12 and 14).
Two days after the last ozone application, the rats were sacrificed by anesthesia overdose (30 mg/kg xylazine and 240 mg/kg ketamine). 23 The rats' left hemimandibles were removed and placed in 10% buffered formalin for subsequent histological processing.
Histopathological and histometric analyses
The tissue samples were fixed in 10% formalin for 24 hours, then decalcified in 10% formic acid and 
Examiner Calibration
All analyses were performed by the same examiner (UPH) who was blind to the treatments. The second measurement was performed seven days after the first measurement to estimate the intraexaminer error. 23 The student t-test was used to determine the examiner calibration in the analyses of the immunolabeling.
Calibration was accepted if the difference between two measurements were not statistically significant (p>0.05).
Statistical Analyses
Statistical analysis was performed using a software program (SPSS, version 20.0; IBM, Chicago, IL, USA). The Kolmogorov-Smirnov test was used for distributional adequacy. The significance of differences between groups was determined by Kruskal-Wallis tests, followed by Dunn multiple comparison post hoc test. The significance level was set at 5%.
Results
A total of 30 Winstar rats (ten rats in each group) were evaluated. ABL, HIF-1-α and RANKL-positive cell values are summarised in Table 1 and Figure 4 .
The highest ABL was in the control group. ABL was statistically and significantly lower in the SO group than in the control group (p: 0.0052). In the TO group ABL was lower than in the control group but this difference was not statistically significant. Ozone therapy improves inflamed tissue oxygenation and reduces total inflammatory process.
In that way, it positively affects some infectious disease outcomes. Ozone therapy can be applied via mixing a range of gases and liquids, and injecting these solutions into the body, including the vagina, rectum, muscle, beneath the skin or by autohemotherapy. 13, 28 There are some studies evaluating the effect of ozone therapys, anti-hypoxic and anti-inflammatory feature, in periodontal tissues. 14, 17, 29 Although there are several studies indicating that topical ozone application with nonsurgical periodontal treatment has no additional benefit in clinical periodontal parameters, 14, [30] [31] [32] few studies have reported significant improvement in periodontal parameters in patients with periodontitis treated with scaling and root planing along with ozone application. 15, 16 Erdemci, et al. 21 (2014) evaluated the effect of SO and TO application after tooth extraction and measured mineralized and trabecular bone and osteoid and osteoblast surfaces for determining alveolar bone healing. They concluded that postoperative long-term SO application can accelerate alveolar bone healing following extraction. In a study evaluating bone healing in the rat calvarial defect model, it has been reported that TO application increases bone formation, and is even more effective than low-level laser therapy on bone healing. 33 It is known that ozone application is effective in the treatment of bisphosphonate-related osteonecrosis of the jaw. 34 Ozdemir, et al. 35 (2013) reported that TO application increased bone formation on autogenous bone grafts in the rat calvarial defect model. In accordance with these studies, in the present study, ABL was decreased in both ozone groups but this change was statistically significant only in the SO group (p:0.005).
Periodontal inflammation is thought to exacerbate local tissue hypoxia in periodontal pockets. In response to the hypoxic condition induced by the inflammatory disease, activation of HIF-1-α is increased and mechanisms that correct the hypoxic state are developed. 3 Researches evaluating HIF-1-α levels in healthy and inflamed periodontal tissues have reported that HIF-1-α levels were higher in inflamed periodontal tissues 6, 36, 37 It has been reported that hypoxic responses of HIF-1-α in periodontal tissues may produce negative feedback mechanisms in the inflammation. 6 These finding demonstrate the importance of the level of HIF-1-α in infectious periodontal tissues. To the best of our knowledge, there is no study evaluating the effect of ozone application on HIF-1-α levels in periodontal inflammation in the literature. However, in an experimental study with soft tissue trauma, there was no statistically significant difference in HIF levels in SO application on soft tissue healing compared to the control group. 38 In another study investigating the effect of SO therapy in diabetic nephropathy rats, HIF-1-α gene expression levels was reported to be decreased in the ozone therapy group. 39 In the present study, HIF-1-α values were lower in both ozone application groups than in the control group. There was no statistically significant difference between SO and TO groups. However, a statistically significant decrease was observed in the TO group compared to the control group. The reason HIF-1-α was lower in the TO group may be because local application reached a more effective concentration than systemic application in the inflammation area.
RANKL leads to osteoclastic differentiation by binding to RANK. 40 RANKL-mediated osteoclastogenesis plays a crucial role in inflammatory bone resorption. It has been reported that RANKL levels increase in the case of hypoxia in human periodontal ligament cells. 10 In this study, RANKL-positive cells were significantly lower in both ozone application groups compared to control group. There was no statistically significant difference in the number of RANKL-positive cells between SO and TO groups. This can explain how the ozone applications reduce the number of RANKLpositive cells by decreasing the hypoxia.
Since the present study is an experimental periodontitis model, the major limitation is that it does not directly adapt to human chronic periodontitis in terms of method, dose and findings.
Conclusion
Within the limitations of this study, it can be concluded that both ozone applications decreased RANKL-positive cell counts, TO application decreased HIF-1-α positive cell counts and SO application was found to be more effective in reducing of ABL compared to the control group. Both applications may thought to be equally effective on experimental periodontitis.
Further clinical studies evaluating the adjunctive use of different ozone application procedures with periodontal therapy are needed to specify clinical benefits.
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